Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Simone Amistadi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chromatin and Gene Regulation during Development, Imagine Institute, INSERM UMR1163, Paris Cité University, Paris, 75015, France. Hauptthemen laut MEDLINE: Fetal Hemoglobin, Epigenesis, Genetic, beta-Globins, Anemia, Sickle Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, Agence Nationale de la Recherches, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Beta-hemoglobinopathies are severe genetic diseases caused by mutations affecting the production of the adult β-globin chain. The clinical severity is mitigated by the co-inheritance of mutations that reactivate the production of the fetal β-like γ-globin in adults. However, the epigenetic mechanisms underlying the adult-to-fetal hemoglobin (HbA-to-HbF) switching are still not fully understood. Here, we used epigenome editing technologies to dissect the molecular mechanisms underlying γ- and β-globin gene regulation and to develop novel potential therapeutics for β-hemoglobinopathies. Targeted removal of DNA methylation by dCas9-Tet1 (alone or together with the deposition of histone acetylation by CBP-dCas9) at the fetal promoters led to efficient and durable γ-globin reactivation, demonstrating that DNA methylation is a driver for HbF repression. This strategy, characterized by high specificity and a good safety profile, led to a substantial correction of the pathological phenotype in erythroid cells from patients with sickle cell disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Chromatin and Gene Regulation during Development, Imagine Institute, INSERM UMR1163, Paris Cité University, Paris, 75015, France.
- Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Imagine Institute, INSERM UMR1163, Paris, 75015, France.
- Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UAR3633, Paris Cité University, Paris, 75015, France.
- Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfants Malades, Paris, 75015, France.
- Department of Molecular Medicine, University of Padova, Padova, 35122, Italy.
- Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, 79098, Freiburg, Germany.
ORCID-Profile: Chiara Magnoni, Claudio Mussolino, Annarita Miccio
Förderung
- French National Research Agency
- Agence Nationale de la Recherches
- European Cooperation in Science and Technology
- Institut Imagine
- Fondation pour la Recherche Médicale
Zitieren
APA
Amistadi, S., Fontana, L., Magnoni, C., Felix, T., Charvin, M. K., Martinucci, P., Gautier, C., Greau, L., Bessières, B., Antoniou, P., Romano, O., Allemand, E., Mussolino, C., & Miccio, A. (2025). Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf637
Vancouver
Amistadi S, Fontana L, Magnoni C, Felix T, Charvin MK, Martinucci P, et al. Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf637
BibTeX
@article{Amistadi2025,
author = {Amistadi, Simone and Fontana, Letizia and Magnoni, Chiara and Felix, Tristan and Charvin, Matteo Kane and Martinucci, Pierre and Gautier, Candice and Greau, Lilian and Bessières, Bettina and Antoniou, Panagiotis and Romano, Oriana and Allemand, Eric and Mussolino, Claudio and Miccio, Annarita},
title = {Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf637}
}
EUVIMED